Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients-authors' response

被引:0
|
作者
Molina, I. [1 ]
Falco, V. [1 ]
Crespo, M. [1 ]
Riera, C. [2 ]
Ribera, E. [1 ]
Curran, A. [1 ]
Carrio, J. [2 ]
Diaz, M. [1 ]
del Saz, S. Villar [1 ]
Fisa, R. [2 ]
Lopez-Chejade, P. [2 ]
Ocana, I. [1 ]
Pahissa, A. [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Infect Dis, E-08193 Barcelona, Spain
[2] Univ Barcelona, Fac Farm, Parasitol Lab, E-08028 Barcelona, Spain
关键词
leishmania; AMB; chemoprophylaxis;
D O I
10.1093/jac/dkm490
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:467 / 467
页数:1
相关论文
共 50 条
  • [21] Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients
    Diro, E.
    Ritmeijer, K.
    Boelaert, M.
    Alves, F.
    Mohammed, R.
    Abongomera, C.
    Ravinetto, R.
    De Crop, M.
    Fikre, H.
    Adera, C.
    Colebunders, R.
    van Loen, H.
    Menten, J.
    Lynen, L.
    Hailu, A.
    van Griensven, J.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 217 - 217
  • [22] VISCERAL LEISHMANIASIS IN HIV-INFECTED PATIENTS IN THE SOUTH OF FRANCE
    DEREURE, J
    REYNES, J
    PRATLONG, F
    LAMAURY, I
    RIOUX, JA
    JANBON, F
    DEDET, JP
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1995, 73 (02) : 245 - 246
  • [23] Visceral leishmaniasis - an opportunistic infection in HIV-infected patients
    Bal, AM
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (04): : 196 - 197
  • [24] Visceral leishmaniasis as a cause of anemia in HIV-infected patients
    Cascio, A
    Iaria, C
    Antinori, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1088 - 1089
  • [25] VISCERAL LEISHMANIASIS AS A CAUSE OF DIARRHEA IN HIV-INFECTED PATIENTS
    PULIDO, F
    RUBIO, R
    COSTA, JR
    [J]. AIDS, 1995, 9 (06) : 661 - 662
  • [26] Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
    Tamiru, Aschalew
    Tigabu, Bethlehem
    Yifru, Sisay
    Diro, Ermias
    Hailu, Asrat
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [27] Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
    Aschalew Tamiru
    Bethlehem Tigabu
    Sisay Yifru
    Ermias Diro
    Asrat Hailu
    [J]. BMC Infectious Diseases, 16
  • [28] Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries
    Berman, JD
    Badaro, R
    Thakur, CP
    Wasunna, KM
    Behbehani, K
    Davidson, R
    Kuzoe, F
    Pang, L
    Weerasuriya, K
    Bryceson, ADM
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1998, 76 (01) : 25 - 32
  • [29] The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis
    Troya, J.
    Casquero, A.
    Muniz, G.
    Fernandez-Guerrero, M. L.
    Gorgolas, M.
    [J]. PARASITOLOGY, 2007, 134 : 621 - 624
  • [30] Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil
    Guedes, Diego Lins
    Medeiros, Zulma
    da Silva, Elis Dionisio
    Martins de Vasconcelos, Audrey Violeta
    da Silva, Mariana Santana
    Lopes da Silva, Maria Almerice
    Ramos de Araujo, Paulo Sergio
    Miranda-Filho, Democrito de Barros
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (06): : 1541 - 1546